Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
about
New developments in the genetics, pathogenesis, and therapy of IgA nephropathyThe Treatment of IgA NephropathyWhat is new in the management of rapidly progressive glomerulonephritis?Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification.Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects.IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.Current pharmacotherapy for the treatment of crescentic glomerulonephritis.Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled studyIn crescentic IgA nephropathy, fractional excretion of IgG in combination with nephron loss is the best predictor of progression and responsiveness to immunosuppression.Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study.Glomerular diseases: emerging tests and therapies for IgA nephropathyClinical outcomes of IgA nephropathy patients with different proportions of crescents.Treatment of IgA nephropathy and Henoch-Schönlein nephritis.Pathology of IgA nephropathy.Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient.Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium.A case of crescentic IgA nephropathy treated with prednisolone and cyclophosphamideClinical and histologic response to methylprednisolone pulse therapy in glomerulonephritis.Comparative study of IgA nephropathy with and without crescents.Successful treatment of rapidly progressive immunoglobulin A nephropathy with human immunodeficiency virus infection by steroid pulse therapy and tonsillectomy.Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology.Primary IgA nephropathy: current challenges and future prospects.A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study
P2860
Q26786248-DE0B99B2-431B-4EEE-BC96-B87AA7A12101Q27005109-40E5BDAF-7E3F-4EA9-99A8-50EE132F54B9Q28259540-6EB09491-7A4E-4198-B112-3E81F8C6FE3CQ34455482-A8CB84D0-B94A-426E-A5A8-8F5A1DAA09ADQ35983485-4E5C4850-53C7-4FD8-876D-AB1F4676719DQ36447934-1242BECD-D8F8-47D8-9005-B7FE9EEA9AF1Q36577108-406682AE-51D9-40DB-9F1F-CE9F06F7FD17Q36623061-4C256A51-84BA-49AE-9732-C9577FD0B29EQ36843397-C4FAA921-28E1-488A-8A9E-673ED0E49891Q37176864-18C46E39-5C62-4A2D-9097-1109506AA4D0Q37340194-7A572E3A-1D9E-411C-AA5C-E5A83211A4E7Q37621563-690A49B8-B7A3-455D-9E1F-6614012AA534Q37725286-24D23E2E-6230-4AA8-9A59-BBDDD62AF7E3Q38094888-7A4F5B37-B011-4D65-B78B-0B660D3AA709Q38214812-32FB9E80-A0FB-42EA-8C2C-2AA9C5A86871Q38783714-49907C48-A6A4-4F7A-B46C-AA335F118657Q38817381-E3AB842F-90A4-456F-974B-6BE496044179Q38860793-D3613EBD-56F6-474A-B2E3-D194BD6463F2Q40545153-BB6A62E1-DE12-42F1-8902-F0D2DDE52F59Q41041794-926487FB-04BC-4B32-8219-7765F9AAB9C2Q42589021-78048557-CC13-45C8-B911-5873BB1F75A8Q42995717-BC961211-DA07-4D0B-ADBB-3D71FCBCED08Q45034710-40325357-2D57-4266-90E4-61C43DC95E05Q45338767-E6A248BB-F731-443A-8C51-5011EC1B8F80Q47592540-2B1B5BBA-4340-49A2-B59B-18DA8333999CQ49477908-492B6368-C2D0-44FC-8326-365D32E2A223Q52309425-C67BF4C3-327B-43D9-9D82-81B77F883CBBQ58747430-F2E8816B-26F6-4BCB-830A-E2C64CA57344
P2860
Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Crescentic, proliferative IgA ...... intravenous cyclophosphamide.
@en
Crescentic, proliferative IgA ...... intravenous cyclophosphamide.
@nl
type
label
Crescentic, proliferative IgA ...... intravenous cyclophosphamide.
@en
Crescentic, proliferative IgA ...... intravenous cyclophosphamide.
@nl
prefLabel
Crescentic, proliferative IgA ...... intravenous cyclophosphamide.
@en
Crescentic, proliferative IgA ...... intravenous cyclophosphamide.
@nl
P2093
P2860
P356
P1476
Crescentic, proliferative IgA ...... intravenous cyclophosphamide.
@en
P2093
James A Tumlin
Randy Hennigar
Verachai Lohavichan
P2860
P304
P356
10.1093/NDT/GFG081
P407
P577
2003-07-01T00:00:00Z